These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 36445262

  • 1. Peripheral glucocorticoid receptor antagonism by relacorilant with modest HPA axis disinhibition.
    Viho EMG, Kroon J, Feelders RA, Houtman R, van den Dungen ESR, Pereira AM, Hunt HJ, Hofland LJ, Meijer OC.
    J Endocrinol; 2023 Feb 01; 256(2):. PubMed ID: 36445262
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant.
    Pivonello R, Munster PN, Terzolo M, Ferrigno R, Simeoli C, Puglisi S, Bali U, Moraitis AG.
    Front Endocrinol (Lausanne); 2021 Feb 01; 12():793262. PubMed ID: 35058882
    [Abstract] [Full Text] [Related]

  • 3. All-trans retinoic acid-induced hypothalamus-pituitary-adrenal hyperactivity involves glucocorticoid receptor dysregulation.
    Hu P, Liu J, Zhao J, Qi XR, Qi CC, Lucassen PJ, Zhou JN.
    Transl Psychiatry; 2013 Dec 17; 3(12):e336. PubMed ID: 24346134
    [Abstract] [Full Text] [Related]

  • 4. The effect of sex and irritable bowel syndrome on HPA axis response and peripheral glucocorticoid receptor expression.
    Videlock EJ, Shih W, Adeyemo M, Mahurkar-Joshi S, Presson AP, Polytarchou C, Alberto M, Iliopoulos D, Mayer EA, Chang L.
    Psychoneuroendocrinology; 2016 Jul 17; 69():67-76. PubMed ID: 27038676
    [Abstract] [Full Text] [Related]

  • 5. The selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity.
    Koorneef LL, Kroon J, Viho EMG, Wahl LF, Heckmans KML, van Dorst MMAR, Hoekstra M, Houtman R, Hunt H, Meijer OC.
    J Endocrinol; 2020 Jul 17; 246(1):79-92. PubMed ID: 32369774
    [Abstract] [Full Text] [Related]

  • 6. Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators.
    Mallick S, Chakrabarti J, Eschbacher J, Moraitis AG, Greenstein AE, Churko J, Pond KW, Livolsi A, Thorne CA, Little AS, Yuen KCJ, Zavros Y.
    Transl Res; 2023 Jun 17; 256():56-72. PubMed ID: 36640905
    [Abstract] [Full Text] [Related]

  • 7. The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas.
    Regazzo D, Mondin A, Scaroni C, Occhi G, Barbot M.
    Int J Mol Sci; 2022 Jun 09; 23(12):. PubMed ID: 35742910
    [Abstract] [Full Text] [Related]

  • 8. Role of enhanced glucocorticoid receptor sensitivity in inflammation in PTSD: insights from computational model for circadian-neuroendocrine-immune interactions.
    Somvanshi PR, Mellon SH, Yehuda R, Flory JD, Makotkine I, Bierer L, Marmar C, Jett M, Doyle FJ.
    Am J Physiol Endocrinol Metab; 2020 Jul 01; 319(1):E48-E66. PubMed ID: 32315214
    [Abstract] [Full Text] [Related]

  • 9. Postnatal glucocorticoid excess due to pituitary glucocorticoid receptor deficiency: differential short- and long-term consequences.
    Schmidt MV, Sterlemann V, Wagner K, Niederleitner B, Ganea K, Liebl C, Deussing JM, Berger S, Schütz G, Holsboer F, Müller MB.
    Endocrinology; 2009 Jun 01; 150(6):2709-16. PubMed ID: 19213843
    [Abstract] [Full Text] [Related]

  • 10. Mifepristone: treatment of Cushing's syndrome.
    Sartor O, Cutler GB.
    Clin Obstet Gynecol; 1996 Jun 01; 39(2):506-10. PubMed ID: 8734015
    [Abstract] [Full Text] [Related]

  • 11. Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder.
    Fries GR, Vasconcelos-Moreno MP, Gubert C, dos Santos BT, Sartori J, Eisele B, Ferrari P, Fijtman A, Rüegg J, Gassen NC, Kapczinski F, Rein T, Kauer-Sant'Anna M.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(1):. PubMed ID: 25522387
    [Abstract] [Full Text] [Related]

  • 12. A naturally hypersensitive glucocorticoid receptor elicits a compensatory reduction of hypothalamus-pituitary-adrenal axis activity early in ontogeny.
    Muráni E, Ponsuksili S, Jaeger A, Görres A, Tuchscherer A, Wimmers K.
    Open Biol; 2016 Jul 31; 6(7):. PubMed ID: 27440422
    [Abstract] [Full Text] [Related]

  • 13. Rapid alteration of stress-induced hypothalamic-pituitary-adrenal hormone secretion in the rat: a comparison of glucocorticoids and cannabinoids.
    Ginsberg AB, Pecoraro NC, Warne JP, Horneman HF, Dallman MF.
    Stress; 2010 May 31; 13(3):248-57. PubMed ID: 20392196
    [Abstract] [Full Text] [Related]

  • 14. Circadian rhythms of glucocorticoid hormone actions in target tissues: potential clinical implications.
    Kino T.
    Sci Signal; 2012 Oct 02; 5(244):pt4. PubMed ID: 23033538
    [Abstract] [Full Text] [Related]

  • 15. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD, Oitzl MS, Workel JO, de Kloet ER.
    Endocrinology; 1996 Nov 02; 137(11):4935-43. PubMed ID: 8895366
    [Abstract] [Full Text] [Related]

  • 16. The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
    Kober P, Rusetska N, Mossakowska BJ, Maksymowicz M, Pękul M, Zieliński G, Styk A, Kunicki J, Działach Ł, Witek P, Bujko M.
    Front Endocrinol (Lausanne); 2023 Nov 02; 14():1124646. PubMed ID: 37065760
    [Abstract] [Full Text] [Related]

  • 17. Acute stress-induced sensitization of the pituitary-adrenal response to heterotypic stressors: independence of glucocorticoid release and activation of CRH1 receptors.
    Belda X, Daviu N, Nadal R, Armario A.
    Horm Behav; 2012 Sep 02; 62(4):515-24. PubMed ID: 22986335
    [Abstract] [Full Text] [Related]

  • 18. Central and peripheral glucocorticoid receptors are involved in the plasma cortisol response to an acute stressor in rainbow trout.
    Alderman SL, McGuire A, Bernier NJ, Vijayan MM.
    Gen Comp Endocrinol; 2012 Mar 01; 176(1):79-85. PubMed ID: 22233772
    [Abstract] [Full Text] [Related]

  • 19. Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.
    Mattsson C, Reynolds RM, Simonyte K, Olsson T, Walker BR.
    J Clin Endocrinol Metab; 2009 Apr 01; 94(4):1347-52. PubMed ID: 19141586
    [Abstract] [Full Text] [Related]

  • 20. Disrupting hypothalamic glucocorticoid receptors causes HPA axis hyperactivity and excess adiposity.
    Laryea G, Schütz G, Muglia LJ.
    Mol Endocrinol; 2013 Oct 01; 27(10):1655-65. PubMed ID: 23979842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.